chr8-22994530-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000519685.5(RHOBTB2):c.-23-31C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.111 in 1,384,776 control chromosomes in the GnomAD database, including 9,584 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.11 ( 974 hom., cov: 32)
Exomes 𝑓: 0.11 ( 8610 hom. )
Consequence
RHOBTB2
ENST00000519685.5 intron
ENST00000519685.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.180
Genes affected
RHOBTB2 (HGNC:18756): (Rho related BTB domain containing 2) The protein encoded by this gene is a small Rho GTPase and a candidate tumor suppressor. The encoded protein interacts with the cullin-3 protein, a ubiquitin E3 ligase necessary for mitotic cell division. This protein inhibits the growth and spread of some types of breast cancer. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
PEBP4 (HGNC:28319): (phosphatidylethanolamine binding protein 4) The phosphatidylethanolamine (PE)-binding proteins, including PEBP4, are an evolutionarily conserved family of proteins with pivotal biologic functions, such as lipid binding and inhibition of serine proteases (Wang et al., 2004 [PubMed 15302887]).[supplied by OMIM, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 8-22994530-C-T is Benign according to our data. Variant chr8-22994530-C-T is described in ClinVar as [Benign]. Clinvar id is 1294929.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.21 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHOBTB2 | NM_001160036.2 | c.-23-31C>T | intron_variant | NP_001153508.1 | ||||
RHOBTB2 | XM_047421607.1 | c.-23-31C>T | intron_variant | XP_047277563.1 | ||||
RHOBTB2 | XM_047421608.1 | c.-23-31C>T | intron_variant | XP_047277564.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHOBTB2 | ENST00000519685.5 | c.-23-31C>T | intron_variant | 1 | ENSP00000427926.1 | |||||
RHOBTB2 | ENST00000524077.5 | c.-23-31C>T | intron_variant | 3 | ENSP00000430785.1 | |||||
PEBP4 | ENST00000522278.1 | c.144+5149G>A | intron_variant | 5 | ENSP00000429414.1 |
Frequencies
GnomAD3 genomes AF: 0.105 AC: 16028AN: 152008Hom.: 966 Cov.: 32
GnomAD3 genomes
AF:
AC:
16028
AN:
152008
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.112 AC: 137627AN: 1232650Hom.: 8610 Cov.: 17 AF XY: 0.114 AC XY: 70309AN XY: 616042
GnomAD4 exome
AF:
AC:
137627
AN:
1232650
Hom.:
Cov.:
17
AF XY:
AC XY:
70309
AN XY:
616042
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.106 AC: 16057AN: 152126Hom.: 974 Cov.: 32 AF XY: 0.109 AC XY: 8102AN XY: 74352
GnomAD4 genome
AF:
AC:
16057
AN:
152126
Hom.:
Cov.:
32
AF XY:
AC XY:
8102
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
851
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at